| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/20/2013 | CN102973796A Traditional Chinese medicine used for treating neurasthenia |
| 03/20/2013 | CN102973793A Health care wine |
| 03/20/2013 | CN102973787A Traditional Chinese medicine used for treating diabetic cardiac autonomic neuropathy |
| 03/20/2013 | CN102973783A Lily rehmanniae decoction anti-depression effective part and preparation method and application thereof |
| 03/20/2013 | CN102973781A Traditional Chinese medicine for treating epilepsia |
| 03/20/2013 | CN102973768A Qianzheng paste for treating acute and chronic facial paralysis |
| 03/20/2013 | CN102973758A Traditional Chinese medicine composition for treating depression |
| 03/20/2013 | CN102973752A Medicament for treating ischialgia |
| 03/20/2013 | CN102973685A Anti-fatigue traditional Chinese medicine preparation and preparation method thereof |
| 03/20/2013 | CN102973682A Long time effective technology for treatment of insomnia |
| 03/20/2013 | CN102973681A Mimosa pudica health-care wine for neurasthenia |
| 03/20/2013 | CN102973619A Process for extracting indoline amide alkaloid from purslane and detection methods for indoline amide alkaloid |
| 03/20/2013 | CN102973618A Method for extracting valerenic acid from valeriana fauriei |
| 03/20/2013 | CN102973614A Probiotics active health-care fluid for preventing and treating senile dementia and preparation method thereof |
| 03/20/2013 | CN102973571A New application of fasudil |
| 03/20/2013 | CN102973563A Application of ombination of esveratrol and piperine used for preparation of medicament for treatment of depression |
| 03/20/2013 | CN102973561A Drug composite for improving sleep and preparation method thereof |
| 03/20/2013 | CN102973551A Use of fisetin for preparing medicaments for treatment of depression. |
| 03/20/2013 | CN102973548A Application of amide compounds in preparation of anti-Alzheimer drugs |
| 03/20/2013 | CN102973531A Levetiracetam medicine composition and preparation method thereof |
| 03/20/2013 | CN102973523A Application of salvianolic acid A lyophilized powder in preparing medicament for protecting ischemic brain tissue damage |
| 03/20/2013 | CN102973522A Application of salvianolic acid A lyophilized powder for preparing medicament for rescuing ischemic penumbra |
| 03/20/2013 | CN102973499A Asarone injection and preparation method thereof |
| 03/20/2013 | CN102973190A Manufacturing method of anthypnotic wet tissue |
| 03/20/2013 | CN102972769A Brain-refreshing health-care food |
| 03/20/2013 | CN102670617B Application of ibuprofen 2-(2-arylmorpholine-4-yl) ethyl ester in preparation of antidepressant drugs |
| 03/20/2013 | CN102533519B Method for preparing male silkworm moth spirits |
| 03/20/2013 | CN102525930B Lipoic acid liposome injection |
| 03/20/2013 | CN102430069B Traditional Chinese medicine for treating delayed epilepsia after cerebral hemorrhage |
| 03/20/2013 | CN102416134B Medicine for treating hypophrenia in children, and preparation method thereof |
| 03/20/2013 | CN102366408B Monosialotetrahexosyl ganglioside sodium liposome injection |
| 03/20/2013 | CN102302644B Traditional Chinese medicine for treating diabetic peripheral neuropathy and preparation method thereof |
| 03/20/2013 | CN102274342B External sticking plaster |
| 03/20/2013 | CN102274268B Traditional Chinese medicine active extract with temperance function, and preparation method and application thereof |
| 03/20/2013 | CN102198248B Traditional Chinese medicine for treating nervous headache |
| 03/20/2013 | CN102188648B Traditional Chinese medicine for treating melancholia |
| 03/20/2013 | CN102178849B Chinese medicine preparation for treating insomnia and preparation method thereof |
| 03/20/2013 | CN102091168B Detection method for Chinese medicine preparation Xuefuzhuyu capsule |
| 03/20/2013 | CN102030743B Iloperidone crystal, and preparation method and medicinal composition thereof |
| 03/20/2013 | CN102002050B Bisbenzylisoquinoline derivative and preparation and application thereof |
| 03/20/2013 | CN101983052B Medicine formulation for the oral transmucosal delivery of triptans |
| 03/20/2013 | CN101785789B Method for preparing animal gall powder |
| 03/20/2013 | CN101653422B Risperidone slow-release microsphere, preparation method and application thereof |
| 03/20/2013 | CN101478980B Alphanizomenon flos aquae preparation, extracts and purified components thereof for the treatment of neurological, neurodegenerative and mood disorders |
| 03/20/2013 | CN101437934B Method of producing dry yeast containing s-adenosyl-l-methionine and composition for oral intake |
| 03/20/2013 | CN101342259B Method for extracting alkaloid valid parts from hooked uncaria leaf, with hook stem branch or full grass and uses thereof |
| 03/20/2013 | CN101247837B Novel salts of conjugated psychotropic drugs and processes of preparing same |
| 03/19/2013 | US8399663 Salt of 1,3,5-triazine-2,4,6-triamine derivative |
| 03/19/2013 | US8399660 Process for the synthesis of triazoles |
| 03/19/2013 | US8399520 Selective estrogen receptor modulator |
| 03/19/2013 | US8399479 Modulators of cystic fibrosis transmembrane conductance regulator |
| 03/19/2013 | US8399473 Macrocyclic spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease |
| 03/19/2013 | US8399469 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 03/19/2013 | US8399415 Oligopeptides and cosmetic compositions containing the oligopeptides |
| 03/19/2013 | US8399414 Analgesics |
| 03/19/2013 | US8399026 Peptides isolated from spider venom, and uses thereof |
| 03/19/2013 | US8399016 Sustained-release tablet composition of pramipexole |
| 03/19/2013 | US8398998 Therapeutic composition comprising a botulinum neurotoxin |
| 03/19/2013 | US8398972 Methods of treating dementia using a GM-CSF antagonist |
| 03/19/2013 | CA2706872C Intermediates for the preparation of lipoxin a4 analogs |
| 03/19/2013 | CA2602444C Acetylenyl-pyrazolo-pyrimidine derivatives as mglur2 antagonists |
| 03/19/2013 | CA2562406C Cyclic amine compound |
| 03/19/2013 | CA2548572C Hydroxylamine derivatives |
| 03/19/2013 | CA2488499C Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives ("statins"),combinations thereof as well as manufacturing of these pharmaceutical compositions |
| 03/14/2013 | WO2013036889A1 Retrograde transport peptide and use of same for delivery to central nervous system |
| 03/14/2013 | WO2013036875A1 Ceramidase and cell differentiation |
| 03/14/2013 | WO2013036835A1 Neuroactive steroids, compositions, and uses thereof |
| 03/14/2013 | WO2013036596A2 Serpinf2-binding molecules and methods of use |
| 03/14/2013 | WO2013036224A1 Use of 1h-quinazoline- 2, 4 -diones for use in the prevention or treatment photosensitive epilepsy |
| 03/14/2013 | WO2013036196A1 Novel thiophene compounds and method for in vivo imaging |
| 03/14/2013 | WO2013035892A1 Piperazine- substituted benzothiophene derivatives as antipsychotic agents |
| 03/14/2013 | WO2013035833A1 Morphinan derivative |
| 03/14/2013 | WO2013035826A1 Fused heterocyclic compound |
| 03/14/2013 | WO2013035712A1 Medicinal agent for treating amyotrophic lateral sclerosis or preventing progression of phase of amyotrophic lateral sclerosis |
| 03/14/2013 | WO2013035109A1 Improved process for the preparation of asenapine maleate |
| 03/14/2013 | WO2013034761A1 Pyridine compounds and uses thereof |
| 03/14/2013 | WO2013034755A1 Triazolopyrazine derivatives and their use for treating neurological and psychiatric disorders |
| 03/14/2013 | WO2013034622A1 Polymorphic form of pridopidine hydrochloride |
| 03/14/2013 | WO2013034550A1 Pramipexole extended release tablets |
| 03/14/2013 | WO2013034506A1 Pde10 modulators |
| 03/14/2013 | WO2013034173A1 Pramipexole extended release tablets |
| 03/14/2013 | WO2013034119A1 4-methylcatechol derivatives und use thereof |
| 03/14/2013 | WO2012178122A3 Phenocopy model of disease |
| 03/14/2013 | WO2012176061A9 Trpv1 antagonists including dihydroxy substituent and uses thereof |
| 03/14/2013 | WO2012123959A3 Copolymer-1, process for preparation and analytical methods thereof |
| 03/14/2013 | WO2012110440A9 6 - cyclobutyl - 1, 5 - dihydro - pyrazolo [3, 4-d] pyrimidin- 4 - one derivatives their use as pde9a inhibitors |
| 03/14/2013 | US20130066069 Processes for preparing substituted pyrimidines |
| 03/14/2013 | US20130065966 Compound Inhibiting Activation of the Enzyme ERK 1/2 To Be Used In The Treatment Of Neurodegenerative Illnesses |
| 03/14/2013 | US20130065963 Histone Deacetylase Inhibitors and Methods of Use Thereof |
| 03/14/2013 | US20130065962 Compounds For Use In The Treatment Of Diseases |
| 03/14/2013 | US20130065961 Modulation of physiological processes and agents useful for same |
| 03/14/2013 | US20130065957 Diclofenac salt of tramadol |
| 03/14/2013 | US20130065944 Reverse micelle system comprising nucleic acids and use thereof |
| 03/14/2013 | US20130065943 Compositions and methods for inhibiting expression of cd45 gene |
| 03/14/2013 | US20130065941 Compositions and their uses for gene therapy of bone conditions |
| 03/14/2013 | US20130065934 Fatty acid cox inhibitor derivatives and their uses |
| 03/14/2013 | US20130065924 Composition and method for the treatment of neurodegeneration |
| 03/14/2013 | US20130065921 Pten inhibitor or maxi-k channels opener |
| 03/14/2013 | US20130065918 Soluble guanylate cyclase activators |
| 03/14/2013 | US20130065916 Crystalline forms of a 3-carboxypropyl-aminotetralin compound |